First in class extra-corporeal ventricular assist device
CardiacAssist developed the TandemHeart® System, an extra-corporeal ventricular assist device, for treatment of cardiogenic shock.
CEO John Marous
Advent Contact Shahzad Malik
Advent invested in 2001 and realised its holding in 2016.
Exited Investments
Privately held CardiacAssist reports record revenues for nine-month financial results
Press Release. Company's TandemHeart(R) extracorporeal circulatory support device continues to gain traction among cardiologists and cardiac surgeons Privately held CardiacAssist Inc. announced today nine-month financial results for 2009.…
Read More